SCHEMBL23808505

SCHEMBL23808505

CC1(C)CC=C(c2cc([C@@]3(O)C[C@@]4(I)O[C@@](C)(C3)[C@H](O)[C@@H]4O)ccc2NC(=O)c2nc(C#N)c[nH]2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13877987 0.94 — —
SCHEMBL4236246 0.94 — —
SCHEMBL14375007 0.88 — —
SCHEMBL13877985 0.88 — —
SCHEMBL23808547 0.88 — —
SCHEMBL14375015 0.87 — —
SCHEMBL4238082 0.86 — —
SCHEMBL13877978 0.86 — —
SCHEMBL23808402 0.86 — —
SCHEMBL4240940 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3208269-B1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2021-09-15 — — EP disclosed
Send feedback